Specific treatment strategies can be evaluated based on these new findings.
Invasive lobular carcinoma of the breast (ILC) is the most common histologic subtype (15% of cases) after invasive ductal carcinoma. Aside from a distinct morphologic appearance, ILC is usually characterized by expression of the estrogen receptor, lack of HER2 amplification, and the absence of E-cadherin (CDH1).
To examine the clinical implications of genomic alterations in ILC, investigators analyzed deletions, insertions, and substitutions in 360 cancer-related genes from 413 ILC primary tumors selected from four biobanks in Europe. They also performed copy number analyses in 170 samples and analyzed germline DNA in uninvolved lymph-node tissue from 196 patients. They then correlated the findings with clinical and pathologic features and o…
Reviewing Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)